GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (FRA:R7E) » Definitions » Total Tax Payable

Cybin (FRA:R7E) Total Tax Payable : €0.00 Mil (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cybin Total Tax Payable?

Cybin's Total Tax Payable for the quarter that ended in Jun. 2024 was €0.00 Mil.


Cybin Total Tax Payable Historical Data

The historical data trend for Cybin's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin Total Tax Payable Chart

Cybin Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Total Tax Payable
- - - - -

Cybin Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cybin Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.


Cybin Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Cybin's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Cybin Business Description

Traded in Other Exchanges
Address
100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.

Cybin Headlines

No Headlines